Alison Burkland, co-founder of MCF portfolio company Nanopath, has been named one of Forbes' 30 under 30

in Portfolio News

Alison Burklund is the cofounder and CTO of Nanopath. Nanopath creates diagnostics that test pelvic and gynecologic infections during a single visit, so treatment can begin right away. Recently, the company closed a Series A funding round of $10 million, bringing its total funding to $11.5 million.

View the article
Investing in Women Code Logo

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.